ArticleCell reports2021

CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment.

Jennifer E Klomp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.